Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents

被引：0
|
作者：
Robert Sidbury
Sady Alpizar
Vivian Laquer
Sunil Dhawan
William Abramovits
Luca Loprete
Jayendar Kumar Krishnaswamy
Faiz Ahmad
Zarif Jabbar-Lopez
Christophe Piketty
机构：
[1] Seattle Children’s Hospital,Departments of Pediatrics and Dermatology
[2] Clinical Research Trials of Florida,undefined
[3] First OC Dermatology,undefined
[4] Center for Dermatology Clinical Research,undefined
[5] Dermatology Treatment and Research Center,undefined
[6] Galderma R&D,undefined
[7] Galderma Laboratories,undefined
[8] LP,undefined
来源：
Dermatology and Therapy | 2022年 / 12卷
关键词：
Nemolizumab; Atopic dermatitis; Biomarkers; Pharmacokinetics; Adolescents;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：631 / 642
页数：11
相关论文
共 50 条
  • [1] Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents
    Sidbury, Robert
    Alpizar, Sady
    Laquer, Vivian
    Dhawan, Sunil
    Abramovits, William
    Loprete, Luca
    Krishnaswamy, Jayendar Kumar
    Ahmad, Faiz
    Jabbar-Lopez, Zarif
    Piketty, Christophe
    [J]. DERMATOLOGY AND THERAPY, 2022, 12 (03) : 631 - 642
  • [2] Study of nemolizumab pharmacokinetics, safety, and efficacy in adolescents with atopic dermatitis
    Sidbury, Robert
    Alpizar, Sady
    Laquer, Vivian
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB114 - AB114
  • [3] Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis
    Freemantle, N.
    Piketty, C.
    [J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2021, 31 (06) : 528 - 529
  • [4] A Reply to "Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis"
    Lin, L.
    Han, Y.
    [J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2021, 31 (06) : 529 - 530
  • [5] Safety, pharmacokinetics, and efficacy of ruxolitinib cream in children and adolescents with atopic dermatitis
    Leung, Donald Y. M.
    Paller, Amy S.
    Zaenglein, Andrea L.
    Tom, Wynnis L.
    Ong, Peck Y.
    Venturanza, May E.
    Kuligowski, Michael E.
    Li, Qian
    Gong, Xiaohua
    Lee, Mark S.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 130 (04) : 500 - +
  • [6] Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis: A Meta-analysis of Randomized Clinical Trials
    Xiao, X.
    Lin, L.
    Zhu, C.
    Yang, X.
    Ni, Y.
    Zhipeng, L.
    Chong, J.
    Han, Y.
    [J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2021, 31 (02) : 190 - 192
  • [7] The role of nemolizumab in the treatment of atopic dermatitis for the adult population
    Prajapati, Stuti
    Flemming, Joseph P.
    Khan, Danyaal
    Han, Haowei
    How, Brian
    Rozenberg, Suzanne Sirota
    Feldman, Steven R.
    [J]. IMMUNOTHERAPY, 2024,
  • [8] Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs
    Steffan, J
    Strehlau, G
    Maurer, M
    Rohlfs, A
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2004, 27 (04) : 231 - 238
  • [9] Efficacy of nemolizumab in atopic dermatitis: Rapid impact on EASI and SCORAD components
    Bouaziz, Jean-David
    Pinter, Andreas
    Alavi, Afsaneh
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB53 - AB53
  • [10] Bullous Pemphigoid that Developed During Nemolizumab Treatment for Atopic Dermatitis: Two Case Reports
    Katsuta, Michie
    Kamide, Ryoichi
    Ishiuji, Yozo
    Nobeyama, Yoshimasa
    Asahina, Akihiko
    [J]. ACTA DERMATO-VENEREOLOGICA, 2024, 104
12345